Categories: News

RadNet, Inc. Announces Date of its Second Quarter 2023 Financial Results Conference Call

LOS ANGELES, July 21, 2023 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2023 financial results on Tuesday, August 8th, 2023 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Investors are invited to listen to RadNet’s conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1626353&tp_key=fb76d167b0.

An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10181301.

About RadNet, Inc.
RadNet, Inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 363 owned and/or operated outpatient imaging centers. RadNet’s markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona. In addition, RadNet provides radiology information technology and artificial intelligence solutions, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of over 9,000 employees.

CONTACTS:

RadNet, Inc.
Mark Stolper
Executive Vice President and Chief Financial Officer
310-445-2800

Staff

Recent Posts

HISENSE UNVEILS NEWEST SMART HOME AND AI INNOVATIONS AT CES 2025

Visit Hisense at Booth 16625 in Central Hall at the Las Vegas Convention Center to…

1 hour ago

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP

VANCOUVER, BC / ACCESSWIRE / December 19, 2024 / BioNxt Solutions Inc. ("BioNxt" or the…

1 hour ago

Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing

Collaboration with Kure.ai to develop ultrafast CAR-T manufacturing process for Hemogenyx Pharmaceuticals' AML Treatment LONDON,…

4 hours ago

Pivot Bio Launches New Retail Distribution Partnerships

Hefty Seed Company Among the First Distribution Partners to Deliver Advanced Nitrogen Solutions Across the…

7 hours ago

Health Net Providing Special Assistance to Members Affected by Bird Flu Throughout California

Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Dec. 18, 2024 /PRNewswire/ --…

7 hours ago

SuperTruth Acquires imaware and Enables Future Of Reliable AI Data Management and Better Health Outcomes

Real-time information aligns with first-party diagnostics to remediate data decay and reveal pristine insights into…

13 hours ago